PD-1/PD-L1 blockade in cervical cancer: current studies and perspectives
Explore this paper's citation graph
Summary
Recent advances in the understanding of the PD-1/PD-L1 signaling pathway are summarized, including the expression patterns of PD- 1/PD/L1 and potential PD-2/2/3/4/5/6 therapeutic strategies for CC.
- Type
- article
- Published
- 2019-03-02
- Cited by
- 46
- References
- 102
- OpenAlex
- https://openalex.org/W30826965
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:73492655
Keywords
Humanities, Political science, Art
References
- Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
- Nonradioactive RNA in situ hybridization detection of human papillomavirus 16-E7 transcripts in squamous cell carcinomas of the uterine cervix using confocal laser scan microscopy.
- PD-L1 and Survival in Solid Tumors: A Meta-Analysis
- Human papillomavirus molecular biology and disease association
- Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
- Prognostic value of programed death ligand 1 in patients with solid tumors: A meta-analysis.
- Accumulation of RNA homologous to human papillomavirus type 16 open reading frames in genital precancers
- Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia
- Changing Paradigms in the Systemic Treatment of Advanced Cervical Cancer
- Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy.
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- Pembrolizumab for the treatment of non-small-cell lung cancer.
- Increased expression of programmed death (PD)‐1 and its ligand PD‐L1 correlates with impaired cell‐mediated immunity in high‐risk human papillomavirus‐related cervical intraepithelial neoplasia
- The human papillomavirus family and its role in carcinogenesis.
- B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells.
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- Basic mechanisms of high‐risk human papillomavirus‐induced carcinogenesis: Roles of E6 and E7 proteins
- Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity.
Cited by
- Immunotherapy for HPV associated cancer
- The immune checkpoints CTLA-4 and PD-L1 in carcinomas of the uterine cervix.
- iTRAQ-based quantitative proteomic analysis of the inhibition of cervical cancer cell invasion and migration by metformin.
- Potential value of V-domain Ig suppressor of T-cell activation for assessing progn osis in cervical cancer and as a target for therapy.
- High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions
- Prognostic Implications of Immune-Related Genes’ (IRGs) Signature Models in Cervical Cancer and Endometrial Cancer
- IMMUNOLOGY OF CERVICAL CANCER.
- In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1
- Association of Programmed Death Ligand 1 and C-X-C Chemokine Receptor Type 4 Immunoexpression with Pelvic Lymph Node Metastasis in Cervical Squamous Cell Carcinoma
- CCR7 Has Potential to Be a Prognosis Marker for Cervical Squamous Cell Carcinoma and an Index for Tumor Microenvironment Change
- Metabolism-Relevant Molecular Classification Identifies Tumor Immune Microenvironment Characterization and Immunotherapeutic Effect in Cervical Cancer
- Case Report: A Case Report and Literature Review on Severe Bullous Skin Reaction Induced by anti-PD-1 Immunotherapy in a Cervical Cancer Patient
- Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases
- 1α,25(OH)2D3(VD3) promotes Raddeanin A-induced anti-proliferative effects on HeLa cell apoptosis and autophagy through negative regulation of HPV18E6-E7/PD-L1/VDR axis
- A Comprehensive Bioinformatic Analysis of Cyclin-dependent Kinase 2 (CDK2) in Glioma.
- A Pan-Cancer Bioinformatic Analysis of RAD51 Regarding the Values for Diagnosis, Prognosis, and Therapeutic Prediction
- Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway
- Relationship and prognostic significance of IL‐33, PD‐1/PD‐L1, and tertiary lymphoid structures in cervical cancer
- LOXL2 small molecule inhibitor restrains malignant transformation of cervical cancer cells by repressing LOXL2-induced epithelial-mesenchymal transition (EMT)
- Monoclonal antibodies in cervical malignancy-related HPV
Related papers
No related papers recorded.